In last trading session, Astera Labs Inc (NASDAQ:ALAB) saw 4.75 million shares changing hands with its beta currently measuring 0.08. Company’s recent per share price level of $68.82 trading at $2.77 or 4.19% at ring of the bell on the day assigns it a market valuation of $11.16B. That closing price of ALAB’s stock is at a discount of -114.17% from its 52-week high price of $147.39 and is indicating a premium of 47.37% from its 52-week low price of $36.22. Taking a look at company’s average trading volume for last 10-days demonstrates a volume of 6.2 million shares which gives us an average trading volume of 5.45 million if we extend that period to 3-months.
For Astera Labs Inc (ALAB), analysts’ consensus is at an average recommendation of Buy while assigning it a mean rating of 1.36. Splitting up the data highlights that, out of 7 analysts covering the stock, 0 rated the stock as a Sell while 0 recommended an Overweight rating for the stock. 1 suggested the stock as a Hold whereas 6 see the stock as a Buy. 0 analyst(s) advised it as an Underweight. The company is expected to be making an EPS of 0.28 in the current quarter.
Astera Labs Inc (NASDAQ:ALAB) trade information
Upright in the green during last session for gaining 4.19%, in the last five days ALAB remained trading in the green while hitting it’s week-highest on Wednesday, 03/12/25 when the stock touched $68.82 price level, adding 3.68% to its value on the day. Astera Labs Inc’s shares saw a change of -48.04% in year-to-date performance and have moved 0.36% in past 5-day. Astera Labs Inc (NASDAQ:ALAB) showed a performance of -33.37% in past 30-days. Number of shares sold short was 9.55 million shares which calculate 1.53 days to cover the short interests.
Wall Street analysts have assigned a consensus price target of 100 to the stock, which implies a rise of 31.18% to its current value. Analysts have been projecting 74 as a low price target for the stock while placing it at a high target of 110. It follows that stock’s current price would drop -7.53% in reaching the projected high whereas dropping to the targeted low would mean a loss of -7.53% for stock’s current value.
Astera Labs Inc (ALAB) estimates and forecasts
This year revenue growth is estimated to rise 70.30% from the last financial year’s standing.
10 industry analysts have given their estimates about the company’s current quarter revenue by setting an average figure of 151.4M for the same. And 9 analysts are in estimates of company making revenue of 159.36M in the next quarter. Company posted 65.26M and 76.85M of sales in current and next quarters respectively a year earlier.
In 2025, company’s earnings growth rate is likely to be around 50.02% while estimates for its earnings growth in next 5 years are of 43.47%.
Astera Labs Inc (NASDAQ:ALAB)’s Major holders
Insiders are in possession of 15.86% of company’s total shares while institution are holding 69.14 percent of that, with stock having share float percentage of 82.17%. Investors also watch the number of corporate investors in a company very closely, which is 69.14% institutions for Astera Labs Inc that are currently holding shares of the company. INTEL CORP is the top institutional holder at ALAB for having 5.9 million shares of worth $357.21 million. And as of 2024-06-30, it was holding 3.8036 of the company’s outstanding shares.
The second largest institutional holder is ATREIDES MANAGEMENT, LP, which was holding about 2.78 million shares on 2024-06-30. The number of shares represents firm’s hold over 1.7889 of outstanding shares, having a total worth of $168.0 million.
On the other hand, Vanguard Total Stock Market Index Fund and Fidelity Growth Company Fund are the top two Mutual Funds which own company’s shares. As of Dec 31, 2024 , the former fund manager was holding 3.73 shares of worth $256.87 million or 2.30% of the total outstanding shares. The later fund manager was in possession of 3.33 shares on Dec 31, 2024 , making its stake of worth around $229.35 million in the company or a holder of 2.06% of company’s stock.
